November 1, 2014     Japanese 
  JCN 
	  Network - Home
JCN Newswire
  Home  |  Companies  | Annual Reports  |  CSR  | News Alerts     
 
Share:
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing
 

Tokyo, June 9, 2014 (JCN) - Sysmex Corporation and Toppan Printing Co., Ltd. are to cooperate for the advancement in the genetic analysis testing industry, and to invest in RIKEN GENESIS Co., Ltd., a Toppan Printing subsidiary. The companies will accelerate their approach to personalized medicine by fostering their technological synergies.

In personalized medicine, gene detection technologies and bioinformatics are playing an important role in providing the most appropriate medical care to respective patients. They do this by analyzing detected gene information to help determine individual conditions such as clinical progress and responsiveness to drug therapies.

Toppan Printing, the Institute of Physical and Chemical Research (RIKEN) and RIKEN Venture Capital Co., Ltd., jointly established RIKEN GENESIS in 2007 to accelerate their practical application in real medical settings and widely promote RIKEN's leading-edge research achievements in the field of personalized medicine.

RIKEN GENESIS, which provides lab-assay services as well as products for genetic testing based on cutting-edge gene analysis technologies and bioinformatics, is one of the few Japanese companies that have technologies for and the experience/ know-how in the field of personalized medicine.

Positioning RIKEN GENESIS at the core of its life science business, Toppan Printing has been proactively working on research and development in the domain of genetic testing for personalized medicine. An example of their efforts involved jointly developing a genetic analysis system that enables quick and easy detection of cancer driving somatic gene mutations.

Sysmex has been enhancing its approach to expand their technological portfolio of in-vitro diagnostics for the realization of personalized medicine through the 2013 acquisition of Inostics GmbH, which possesses digital PCR technology2, open innovation with research institutes, universities and medical institutions for biomarker acquisition, and other activities.

Toppan Printing, Sysmex and Riken Genesis have found a common direction in personalized medicine by genetic testing technologies through anticipated technological synergies.

Through this alliance, the companies will aim at expanding platforms for genetic testing technologies and, on a short term basis, global distribution of the Japan-oriented companion diagnostics. This will be achieved by utilizing the pipeline of companion diagnostics projects with pharmaceutical companies in both RIKEN GENESIS and Sysmex.

From the mid-to-long term perspective, the companies will accelerate their approach to personalized medicine by providing high-value biomarkers as new clinical tests to practical medicine through the flexibly to respond to various needs for genetic testing at each stage and supporting a seamless connection between them.

The companies are aiming to establish a place in the global market for Japan-oriented genetic testing technologies by bringing out their comprehensive capabilities in genetic testing as well as driving research and development and business operations.

By Jun Ota Staff Writer

Copyright © 2014 JCN. All rights reserved. A division of Japan Corporate News Network KK.


 Company Profile |   Print  |   Alerts
ACN Newswire

 Recent  Sysmex News  
  Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing  (June 9, 2014)
  Sysmex Announces Establishment of Sysmex Vietnam Sales and Support Subsidiary  (Mar 17, 2010)
  Sysmex Starts Joint Research with National Cancer Center Hospital to Verify Clinical Usefulness of Technology for Detecting Circulating Tumor Cells  (Mar 16, 2010)
  Sysmex Announces Establishment of Overseas Subsidiary in Spain to Expand Life Science Business  (Jan 13, 2010)
  Sysmex and Epigenomics of Germany to Start Joint Research on Technology for Early Detection of Colorectal Cancer  (Jan 22, 2009)
  Sysmex Develops a Highly Sensitive Technology for Detection of Circulating Tumor Cells  (Jan 21, 2009)
  Sysmex Intros Japan's First Rapid Influenza Diagnostic Kit for Chickens  (Dec 16, 2008)
  Sysmex Allowed to Sell Avian Flu Detection Kit  (May 1, 2008)
  Sysmex Allowed to Sell Avian Flu Detection Kit  (May 1, 2008)
  Sysmex to Establish New R&D Center in Germany  (June 29, 2006)



 Recent  Biotech News   
Otsuka's 'QuickNavi-Flu' Diagnostic Kit to Provide Additional Diagnosis-Related Information (Oct 14, 2014)
Nitto Denko Anti-fibrosis Drug Starts Phase-1b Dosing for Cirrhosis Patients in the US (Oct 10, 2014)
Mitsui to Participate in KIFMEC Specific Purpose Company (Aug 18, 2014)
Yokogawa Technology Selected for JSTA's Next-generation Technology Transfer Program (Aug 8, 2014)
Sysmex, Toppan Printing to Collaborate in Genetic Analysis Testing (June 9, 2014)
Takara Bio Submits IND Application to FDA for HF10 Anti-cancer Therapy (May 12, 2014)
Nitto Denko Anti-fibrosis Drug with Molecular Targeting DDS Completes Phase-1a Dose Escalation (Apr 24, 2014)
Kaneka, RIKEN Synthesize Bioplastic from Non-food Plant Resources
 (Apr 14, 2014)
Takara Bio Completes Enrollment for Phase I Clinical Trial in the US for HF10 Anti-Cancer Therapy (Apr 10, 2014)
Dainippon Sumitomo Pharma Establishes Anti-Cancer Drugs Sales Company in the U.S. (Oct 10, 2013)

More Biotech news...
 
CSR Report Download
Annual Reports

  More >>    
Most Popular


About JCN | Privacy Policy | Terms of Use | JCN Network (日本語)